Perimenopause, decoded.

Editorial summary.

Perimenopause is the multi-year window before menopause when estrogen and progesterone stop running on the steady, predictable cycle most women have spent their adult life on. It typically begins somewhere between 35 and 47, lasts an average of four to eight years, and ends when you have gone twelve consecutive months without a period. The average age of menopause in the U.S. is 51 — perimenopause routinely starts a decade before that, and frequently earlier than women are told to expect.

The clinical picture worth knowing: hormones do not gracefully decline in a smooth downward slope. They oscillate. Estradiol can swing higher than it ever was before swinging meaningfully lower, sometimes within the same cycle. Progesterone tends to fall earlier and more predictably, which is part of why sleep, mood and cycle regularity often shift first. The result, lived from the inside, is a body that feels like it has changed the rules without telling you.

The most common pattern Heme sees in editorial inbound: a woman in her late 30s or early 40s notices sleep fragmenting, cycle length changing, mood harder to manage in the second half of the cycle, brain fog where there wasn't any. She raises it with her provider. She is told she is "too young," that it is "just stress," or that there is nothing to test for. None of those are accurate. There are markers worth measuring, conversations worth having, and options worth knowing about. This page walks through them.

What perimenopause is.

Perimenopause means "around menopause." It is the transition phase during which the ovaries begin to produce hormones less reliably — not less in a single direction, but less reliably. Some cycles still ovulate. Some don't. Estradiol can spike to levels above premenopausal baseline one month and drop to postmenopausal levels the next. Progesterone, which is produced after ovulation, declines earlier on average because anovulatory cycles become more common. The system that ran on autopilot for twenty-plus years starts improvising.

The body responds to this hormonal noise in ways that are downstream and frequently confusing. Sleep architecture changes. The classic 3 a.m. wake-up, lying in bed alert until 5, is partly an estradiol fluctuation pattern and partly a progesterone-and-GABA story — progesterone has calming, sleep-supporting effects that fade as cycles become anovulatory. Mood becomes more reactive. Hot flashes and night sweats can show up years before the period stops. Joint aches, dry skin, hair thinning, and changes to body composition can all begin in early perimenopause and get attributed to "getting older" rather than to the hormonal shift driving them.

It helps to think of perimenopause in two rough phases. Early perimenopause looks like cycles that are still roughly regular but starting to vary — shorter, longer, heavier, lighter, more PMS, more breast tenderness, more sleep disruption around the period. Late perimenopause is when cycles start to skip — sixty days, ninety days, then another period — and the more recognisable vasomotor symptoms (hot flashes, night sweats) tend to intensify. Menopause itself is a single moment in time: the day twelve consecutive months without a period have elapsed. Everything before that twelve-month mark is perimenopause, even if your last period was eleven months ago.

The reason this matters for testing: hormone labs are most informative when interpreted against where you are in this transition, not against a single reference range. A high FSH on day three of a cycle in a 44-year-old means something different than a high FSH in a 52-year-old who has not bled in nine months. Context is most of the diagnosis.

Common signs and patterns.

These are clusters that frequently appear together in perimenopause. None of them, individually, is diagnostic. Together, in a woman between 35 and 52, they form a pattern worth raising with a qualified healthcare provider.

• —Cycle changes. Cycle length shortening (28 to 25 days), then later lengthening or skipping. Heavier or lighter flow. New clotting. Spotting between periods. PMS that feels more intense than in your 20s and 30s.
• —Sleep shifts. Falling asleep is usually fine; staying asleep is the problem. Waking at 3 a.m. and lying alert until 5. Night sweats that don't fully wake you but fragment the sleep underneath.
• —Mood and cognition. Anxiety that feels less reasoned than usual. Lower stress threshold, particularly premenstrually. Word-finding lapses. The "what did I come in here for" pattern at a frequency that feels new.
• —Vasomotor symptoms. Hot flashes, often subtle at first — a sudden warmth in the chest or face that passes in a minute. Night sweats. Some women never get either; most get some version of both.
• —Body and metabolic shifts. Body composition changing despite the same diet and training. Weight redistributing toward the midsection. Joint aches — particularly hands, shoulders, knees. Skin and hair drier. Hair shedding more than usual.
• —Libido and genitourinary changes. Lower libido. Vaginal dryness. New discomfort with intercourse. More frequent UTIs. These tend to arrive later in the transition and warrant their own conversation.

If three or more of these clusters describe your last six months and you are between 35 and 52, perimenopause is worth raising explicitly with your provider — even if it isn't the first explanation offered.

"Perimenopause is the body changing the rules without telling you. The fact that you noticed is not a failure of resilience. It's accurate observation."

The biomarkers worth knowing.

Bloodwork in perimenopause is genuinely harder to interpret than bloodwork at other life stages, because hormones swing day-to-day and cycle-to-cycle. That makes timing and context more important, not the testing itself less useful. A reasonable panel — read by someone who understands the transition — gives a fuller picture than the standard 15-minute primary-care visit usually produces.

None of these markers is useful in isolation. Read together, in the context of your cycle, your symptoms and your age, they answer a more useful question than a single FSH value ever can. Timing matters — your provider or testing service should be able to advise on when in the cycle to draw, and whether re-testing across cycles is worth it.

If your current provider declines the conversation entirely, a second opinion is reasonable. Telehealth options that specialise in menopause care (Midi, Alloy, Evernow) exist precisely because dismissive responses remain common in standard primary care.

What may help.

Perimenopause has a wider range of evidence-supported levers than the standard "just push through it" framing suggests. None of these are universally appropriate — what makes sense for one woman won't make sense for another, and the conversation belongs with a qualified clinician. The honest summary of categories worth knowing about.

6.1 Menopause hormone therapy (MHT)

The 2002 Women's Health Initiative findings produced two decades of overcorrection. Current evidence — and the position of major menopause societies — is that for most women who begin treatment within ten years of menopause and under 60, the benefits of MHT for vasomotor symptoms, sleep, mood, bone density and genitourinary health may outweigh the risks. The conversation is individual, not universal. Worth raising explicitly with a clinician who treats menopause — not assumed to be off the table.

6.2 Sleep architecture support

Sleep tends to be the symptom that breaks first and matters most. Levers worth experimenting with under guidance: cooler bedroom (lower 60s Fahrenheit), consistent wake time including weekends, last caffeine before 1 p.m., reduced or eliminated evening alcohol (one of the most underrated fatigue and sleep disruptors at this stage), and a screens-off window in the last hour before bed. None of these replace clinical conversations, but they widen what those conversations have to work with.

6.3 Resistance training and protein

The evidence base for resistance training in perimenopause is unusually strong — for sleep, mood, bone density, body composition and metabolic health. Most women need more protein than they're consuming (roughly 1.2–1.6 g/kg body weight per day is a commonly cited target for perimenopausal women), and most women need real resistance work two to three times a week to maintain lean mass through and after the transition.

6.4 Targeted supplementation

Where labs identify gaps, replacing them tends to be the lowest-effort, highest-yield intervention. Common ones worth measuring against rather than guessing about: vitamin D if 25-OH is below 30 ng/mL, magnesium glycinate for sleep and muscle cramping, omega-3s for mood and lipid support, and iron only if ferritin specifically supports it. Supplementing iron when it isn't needed is not a benign decision.

6.5 Comprehensive testing as a baseline

Drawing a baseline panel in early perimenopause — hormones timed to the cycle, thyroid, ferritin, vitamin D, lipids, HbA1c — and re-running it every twelve to eighteen months gives you a trajectory rather than a single snapshot. The two services covered in our comparison page that handle perimenopause-relevant panels most thoughtfully are Function Health (annual subscription, comprehensive) and LetsGetChecked's Women's Health Comprehensive (one-off snapshot).

When to seek a clinician.

Heme is an editorial layer, not a clinic. The patterns below are worth taking seriously — not as a diagnosis, but as a reason to move the conversation off this page and into a clinical one with someone qualified to see you in context.

Bloodwork is the starting point of this conversation, not the endpoint. Your primary care provider, OB-GYN, women's-health nurse practitioner, or a menopause-trained clinician is the right next step once results are in hand. If you're not getting the conversation you need, a second opinion is reasonable — particularly on this transition, where dismissive responses remain common in standard primary care.